How many MD Pathology (IHC & Molecular Pathology) thesis topics are available?

80+ MD Pathology (IHC & Molecular Pathology) thesis topics are listed on this page, covering the major subsections of the curriculum. Click "Get Objectives" on any title to unlock them instantly.

Do these Pathology (IHC & Molecular Pathology) topics include the objectives?

Yes. Every title has a worked-out objective, synopsis structure, sample-size calculation and statistical plan. Click "Get Objectives" on any title to unlock its aim, objectives and hypothesis instantly, or "Full Plan" for the complete synopsis.

Is this useful for MD, DNB and FCPS Pathology (IHC & Molecular Pathology) candidates?

Yes. These thesis topics are aligned with NMC, NBE and DNB Pathology (IHC & Molecular Pathology) curricula and suit MD, DNB Pathology (IHC & Molecular Pathology) and FCPS candidates alike.

Can you help with synopsis, protocol and data analysis too?

Yes. Beyond topic selection, our team provides synopsis writing, IEC/IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS/R), thesis writing and journal publication support.

IHC & Molecular Pathology Thesis Topics for MD Pathology 2026

001

Pattern of cervical precancerous lesions on cervical biopsy with p16 immunohistochemistry

Immunohistochemistry & Molecular Pathology Prospective observational study Clinical Spectrum / Profile

Objective

MD Pathology (IHC & Molecular Pathology) — Thesis Title List

Pattern of cervical precancerous lesions on cervical biopsy with p16 immunohistochemistry

Expression of Ki-67 in thyroid neoplasms and its correlation with histopathological type

Association of ER, PR and HER2 status with histological grade and lymph node status in invasive breast carcinoma

Correlation of Ki-67 index with molecular subtype in invasive breast carcinoma

Role of immunohistochemistry panel in subtyping of lymphoma in lymph node biopsies

Expression of HER2 in breast carcinoma with emphasis on HER2-low status and its association with clinicopathological factors

Androgen receptor expression in triple-negative breast carcinoma and its association with tumour grade and Ki-67

TRPS1 immunohistochemistry in breast carcinoma and its comparison with GATA3 as a breast lineage marker

Ki-67 proliferation index in meningiomas and its correlation with WHO grade

p16 immunohistochemistry in cervical intraepithelial neoplasia and its role in grading cervical lesions

Mismatch repair protein expression by immunohistochemistry in colorectal carcinoma and its clinicopathological correlates

PD-L1 expression in oral squamous cell carcinoma and its association with tumour stage and nodal status

Immunohistochemical expression of BCL-2 and CD10 in diffuse large B-cell lymphoma and cell-of-origin classification by the Hans algorithm

CK7 and CK20 immunoprofile in carcinomas of unknown primary and its utility in predicting site of origin

Immunohistochemical expression of p53 and Ki-67 in urothelial carcinoma and its association with grade and stage

Immunohistochemistry on cell blocks of serous effusions in distinguishing reactive mesothelial cells from metastatic carcinoma

Calretinin immunohistochemistry in the diagnosis of Hirschsprung disease on rectal biopsies

Estrogen and progesterone receptor expression in endometrial carcinoma and its association with histological grade

IDH1 R132H and ATRX immunohistochemistry in diffuse gliomas and integration with histological diagnosis

PRAME and SOX10 immunohistochemistry in distinguishing cutaneous melanoma from benign melanocytic naevi

p53 immunohistochemistry patterns in endometrial carcinoma as a surrogate for molecular classification and their association with histological type

HER2 immunohistochemistry in gastric and gastro-oesophageal junction adenocarcinoma and its association with Lauren histological type

INSM1 versus synaptophysin and chromogranin immunohistochemistry in the diagnosis of neuroendocrine neoplasms

PD-L1 combined positive score in squamous cell carcinoma of the cervix and its association with FIGO stage

STAT6 immunohistochemistry in the diagnosis of solitary fibrous tumour and its distinction from histological mimics

WT1, PAX8 and p53 immunoprofile in high-grade serous carcinoma versus other ovarian epithelial tumours

MYC and BCL2 dual expression in diffuse large B-cell lymphoma and its association with clinical stage and International Prognostic Index

HER2 immunohistochemical expression in urothelial carcinoma and its association with grade and muscle invasion

Ki-67 index versus mitotic count for grading gastroenteropancreatic neuroendocrine tumours: a concordance study

EGFR mutation testing by real-time PCR in non-small cell lung carcinoma biopsies and its association with histological subtype and smoking

ALK D5F3 immunohistochemistry in lung adenocarcinoma and its concordance with fluorescence in situ hybridisation

CD117 and DOG1 immunohistochemical expression in gastrointestinal stromal tumours and association with risk category

ERG immunohistochemistry in prostatic adenocarcinoma and its association with ISUP grade group and serum PSA

Mismatch repair protein immunohistochemistry in endometrial carcinoma and its association with histological type, grade and myometrial invasion

PD-L1 (22C3) tumour proportion score in non-small cell lung carcinoma biopsies and its association with histological subtype and EGFR mutation status

BRAF V600E (VE1) immunohistochemistry in papillary thyroid carcinoma and its association with histological variant and extrathyroidal extension

NKX3.1 versus PSA immunohistochemistry in establishing prostatic origin of metastatic carcinoma in biopsy specimens

SATB2 versus CDX2 immunohistochemistry in identifying colorectal origin of metastatic adenocarcinoma

p40 versus p63 immunohistochemistry in distinguishing squamous cell carcinoma from adenocarcinoma in small lung biopsies

TTF-1 and Napsin A immunohistochemistry in distinguishing primary lung adenocarcinoma from metastatic adenocarcinoma in lung biopsies

Cyclin D1 and SOX11 immunohistochemistry in the diagnosis of mantle cell lymphoma and its distinction from other small B-cell lymphomas

Immunohistochemical profile of classical Hodgkin lymphoma with CD15, CD30, PAX5 and EBV-LMP1 and its association with histological subtype

Hot-spot versus global scoring of Ki-67 index in invasive breast carcinoma according to International Ki67 in Breast Cancer Working Group recommendations

HER2 FISH amplification in breast carcinomas with equivocal (2+) immunohistochemistry according to ASCO/CAP guidelines and associated clinicopathological features

E-cadherin immunohistochemistry in distinguishing invasive lobular from invasive ductal breast carcinoma

p16 immunohistochemistry as a surrogate marker of HPV in oropharyngeal squamous cell carcinoma and its clinicopathological correlates

p53 and Ki-67 expression across grades of oral epithelial dysplasia and oral squamous cell carcinoma

Claudin 18.2 expression by immunohistochemistry in gastric adenocarcinoma and its association with HER2 status and tumour stage

HER2 overexpression in colorectal adenocarcinoma and its association with tumour location, grade and stage

Microvessel density by CD34 immunohistochemistry in colorectal carcinoma and its association with tumour stage and nodal metastasis

Immunohistochemistry versus Giemsa staining for detection of Helicobacter pylori in gastric biopsies with chronic gastritis

CD68 and CD163 tumour-associated macrophages in oral squamous cell carcinoma and their association with nodal metastasis and grade

Loss of PTEN expression in endometrial hyperplasia and endometrioid carcinoma and its diagnostic role in atypical hyperplasia

AMACR (racemase) and p63 immunohistochemistry in the diagnosis of small foci of adenocarcinoma in prostatic needle biopsies

Glypican-3, HepPar-1 and arginase-1 immunohistochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma in liver biopsies

Inhibin and calretinin immunohistochemistry in the diagnosis of ovarian sex cord-stromal tumours and their distinction from mimics

Immunohistochemical subtyping of ampullary carcinoma into intestinal and pancreatobiliary types using CK7, CK20, CDX2 and MUC1

KRAS mutation analysis by real-time PCR in colorectal carcinoma and its association with clinicopathological features and MMR status

Mismatch repair deficiency by immunohistochemistry in gastric adenocarcinoma and its association with Lauren histological type and stage

PD-L1 (22C3) combined positive score in triple-negative breast carcinoma and its association with tumour-infiltrating lymphocytes

Nuclear beta-catenin immunohistochemistry in distinguishing desmoid fibromatosis from other fibroblastic and spindle cell lesions

HBME-1, galectin-3 and CK19 immunohistochemistry in differentiating benign from malignant follicular-patterned thyroid lesions

COX-2 immunohistochemical expression along the colorectal adenoma-carcinoma sequence and its association with dysplasia grade

Residual cancer burden after neoadjuvant chemotherapy in breast carcinoma and its association with pre-treatment Ki-67 and molecular subtype

Concordance of ER, PR and HER2 status between core needle biopsy and subsequent excision specimens in invasive breast carcinoma

CK5/6 and EGFR immunohistochemistry for identifying the basal-like phenotype in triple-negative breast carcinoma and its association with grade

Somatostatin receptor 2A immunohistochemistry in gastroenteropancreatic neuroendocrine tumours and its association with WHO grade

Claudin 18.2 immunohistochemical expression in gastric and gastro-oesophageal junction adenocarcinoma and its clinicopathological correlation

Frequency of mismatch repair protein deficiency by immunohistochemistry in colorectal carcinoma among patients younger than 50 years

Immunohistochemical expression of SATB2 and CDX2 in differentiating colorectal from non-colorectal metastatic adenocarcinomas

PD-L1 combined positive score in urothelial carcinoma of the urinary bladder and its correlation with grade, muscle invasion and tumour-infiltrating lymphocytes

HER2 immunohistochemical expression and HER2-low status in ovarian and endometrial serous carcinomas at a tertiary care centre

HER2 immunohistochemical expression in gallbladder carcinoma and its association with tumour grade, stage and lymph node status

Concordance between manual counting and digital image analysis for Ki-67 proliferation index in invasive breast carcinoma

Correlation between Ki-67 labelling index and mitotic count in head and neck squamous cell carcinoma and their association with tumour grade

BCL2 immunohistochemical expression in invasive breast carcinoma and its association with hormone receptor status, grade and molecular subtype

Cell-of-origin subtyping of diffuse large B-cell lymphoma by the Hans algorithm and its association with International Prognostic Index and extranodal disease

CD4 and CD8 tumour-infiltrating lymphocytes in oesophageal squamous cell carcinoma and their association with tumour stage and nodal status

Vasculogenic mimicry by CD31/PAS dual staining in colorectal adenocarcinoma and its association with tumour grade, budding and metastasis